CD34 and infection: Selective depletion of CD45RA naïve T cells preserves the CD34+ fraction, critical for engraftment and CD45RO memory cells that could maintain T cell activity against infections and tumors, but unfortunately, this strategy has not produced encouraging results so far [84].